Date published: 2026-1-19

1-800-457-3801

SCBT Portrait Logo
Seach Input

Cdk1 Inhibitor (CAS 220749-41-7)

5.0(1)
Write a reviewAsk a question

See product citations (3)

Application:
Cdk1 Inhibitor is an indolylmethylene-2-indolinone anti-proliferative agent
CAS Number:
220749-41-7
Purity:
>95%
Molecular Weight:
294.7
Molecular Formula:
C17H11ClN2O
For Research Use Only. Not Intended for Diagnostic or Therapeutic Use.
* Refer to Certificate of Analysis for lot specific data.

QUICK LINKS

Cdk1 Inhibitor is an indolylmethylene-2-indolinone derivative that exhibits potent anti-proliferative properties (IC50 = 2 µM HeLa cells). Cdk1 Inhibitor acts as a selective and ATP-competitive inhibitor of Cdk1/cyclin B (IC50 = 5.8 µM). Also inhibits Cdk5 with a IC50 = 25 µM. Binds to the ATP pocket on the Cdk1 active site. Does not affect the activity of GSK-3b even at 100 µM concentrations.


Cdk1 Inhibitor (CAS 220749-41-7) References

  1. Imidazo[2,1 -b]thiazolylmethylene- and indolylmethylene-2-indolinones: a new class of cyclin-dependent kinase inhibitors. Design, synthesis, and CDK1/cyclin B inhibition.  |  Andreani, A., et al. 2000. Anticancer Drug Des. 15: 447-52. PMID: 11716438
  2. Cyclin-dependent kinase 2 controls peripheral immune tolerance.  |  Chunder, N., et al. 2012. J Immunol. 189: 5659-66. PMID: 23136201
  3. Potential antitumor agents. 25 [1]. Synthesis and cytotoxic activity of 3-(2-chloro-3-indolylmethylene)1,3-dihydroindol-2-ones.  |  Andreani, A., et al. 1996. Anticancer Res. 16: 3585-8. PMID: 9042225

Ordering Information

Product NameCatalog #UNITPriceQtyFAVORITES

Cdk1 Inhibitor, 5 mg

sc-202529
5 mg
$124.00